<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Concepts and models for drug permeability studies</title>
    <subTitle>cell and tissue based In vitro culture models</subTitle>
  </titleInfo>
  <name type="personal">
    <namePart>Sarmento, Bruno</namePart>
    <role>
      <roleTerm type="text">editor.</roleTerm>
    </role>
  </name>
  <typeOfResource>text</typeOfResource>
  <genre authority="marc">bibliography</genre>
  <genre authority="">Electronic books.</genre>
  <genre authority="">Electronic books.</genre>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">ne</placeTerm>
    </place>
    <place>
      <placeTerm type="text">Amsterdam</placeTerm>
    </place>
    <publisher>Elsevier</publisher>
    <dateIssued>2016</dateIssued>
    <dateIssued>�2016</dateIssued>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <form authority="gmd">electronic resource</form>
    <extent>1 online resource.</extent>
  </physicalDescription>
  <tableOfContents>Front Cover; Related titles; Concepts and Models for Drug Permeability Studies; Copyright; Contents; List of contributors; List of figures; List of tables; 1 -- Introduction; 1.1 Introduction; References; 2 -- Importance and applications of cell- and tissue-based in vitro models for drug permeability screening in early stages o ...; 2.1 Introduction; 2.2 General considerations; 2.3 Drug transport; 2.3.1 Transport mechanisms; 2.4 Permeability-absorption models; 2.4.1 Physicochemical methods; 2.4.1.1 Physicochemical factors; 2.4.1.2 Immobilized artificial membrane chromatography</tableOfContents>
  <tableOfContents>2.4.1.3 Parallel artificial membrane permeability assay2.4.2 In vitro cell and tissue methods; 2.4.2.1 Cell-based methods; 2.4.2.2 Tissue-based methods; Diffusion chambers; Franz cells; Everted sacs; Isolated membrane vesicles; 2.5 Methods for permeability calculation; 2.6 Standardization of protocols for in vitro methods; 2.7 The "three Rs" principle; 2.8 Biosecurity systems; References; 3.1 -- Cell-based in vitro models for buccal permeability studies; 3.1.1 Introduction; 3.1.2 Physiology of the buccal mucosa; 3.1.3 Different in vitro models; 3.1.3.1 Hamster cheek pouch cells</tableOfContents>
  <tableOfContents>3.1.3.2 TR146 cell line3.1.3.2.1 Protocol; Cell culture conditions; Permeability studies; 3.1.3.3 Human oral keratinocytes; 3.1.3.3.1 Protocol; Oral keratinocyte culture conditions; Culturing on dead de-epidermized dermis (DDED); Permeability studies; 3.1.3.4 MatTek EpiOral"; 3.1.3.4.1 Protocol; Cell culture conditions; Permeability studies; 3.1.4 Conclusions; References; 3.2 -- Cell-based in vitro models for gastric permeability studies; 3.2.1 The stomach as a natural barrier to absorption; 3.2.2 Gastric drug delivery; 3.2.2.1 Molecular absorption in the stomach</tableOfContents>
  <tableOfContents>3.2.2.2 Physicochemical factors mediating stomach absorptive permeability3.2.3 Cellularized models of gastric permeability; 3.2.3.1 Protocol for establishing cellularized artificial models of the gastric wall; 3.2.4 Conclusions; Acknowledgments; References; 3.3 -- Cell-based in vitro models for intestinal permeability studies; 3.3.1 Anatomy and physiology of human small intestine; 3.3.1.1 Stromal-epithelial cross-talk; 3.3.2 Mechanisms of transport; 3.3.3 Intestinal barriers; 3.3.4 Intestinal in vitro models; 3.3.4.1 Caco-2 model; 3.3.4.1.1 Accelerated Caco-2 models</tableOfContents>
  <tableOfContents>3.3.4.1.2 Alternatives to the Caco-2 model3.3.4.2 Caco-2/HT29-MTX model; 3.3.4.3 Caco-2/Raji B model; 3.3.4.4 Caco-2/HT29-MTX/Raji B; 3.3.4.5 Novel 3D in vitro models; 3.3.5 Validation studies; 3.3.6 Conclusions; References; 3.4 -- Cell-based in vitro models for nasal permeability studies; 3.4.1 Introduction; 3.4.2 Nasal primary cell culture models; 3.4.2.1 Sampling approaches and procedures; 3.4.2.2 HNE cell preparation and culture initiation; 3.4.3 Immortalized nasal cell lines; 3.4.3.1 RMPI 2650 cell line; 3.4.3.2 BT cell line; 3.4.3.3 Human lung carcinoma cell line</tableOfContents>
  <note type="statement of responsibility">edited by Bruno Sarmento.</note>
  <note>&lt;strong&gt;Off-Campus Access:&lt;/strong&gt; Athens ID and Password Required</note>
  <note>&lt;strong&gt;On-Campus Access:&lt;/strong&gt; No User ID or Password Required</note>
  <note>Includes bibliographical references and index.</note>
  <note>Electronic access restricted to authorized BRAC University faculty, staff and students</note>
  <note>Mode of access: Internet</note>
  <subject authority="lcsh">
    <topic>Cell culture</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Drugs</topic>
    <topic>Physiological transport</topic>
    <topic>Research</topic>
    <topic>Methodology</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Drugs</topic>
    <topic>Testing</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Epithelial cells</topic>
  </subject>
  <subject authority="fast">
    <topic>Cell culture</topic>
  </subject>
  <subject authority="fast">
    <topic>Drugs</topic>
    <topic>Testing</topic>
  </subject>
  <subject authority="fast">
    <topic>Epithelial cells</topic>
  </subject>
  <subject authority="bisacsh">
    <topic>MEDICAL / Pharmacology</topic>
  </subject>
  <subject authority="mesh">
    <topic>Permeability</topic>
  </subject>
  <subject authority="mesh">
    <topic>Pharmacokinetics</topic>
  </subject>
  <subject authority="mesh">
    <topic>Cell Culture Techniques</topic>
  </subject>
  <subject authority="mesh">
    <topic>Models, Biological</topic>
  </subject>
  <subject authority="mesh">
    <topic>Pharmaceutical Preparations</topic>
    <topic>metabolism</topic>
  </subject>
  <subject authority="mesh">
    <topic>Tissue Culture Techniques</topic>
  </subject>
  <classification authority="lcc">RM301.25</classification>
  <classification authority="ddc" edition="23">615.1901</classification>
  <classification authority="nlm">2015 L-371</classification>
  <classification authority="nlm">QV 38</classification>
  <relatedItem type="otherFormat" displayLabel="Print version:">
    <identifier type="local">(OCoLC)911073450</identifier>
  </relatedItem>
  <relatedItem type="series">
    <titleInfo>
      <title>Woodhead Publishing series in biomedicine ; no. 79</title>
    </titleInfo>
  </relatedItem>
  <identifier type="isbn">0081001142</identifier>
  <identifier type="isbn">9780081001141</identifier>
  <identifier type="isbn" invalid="yes"/>
  <identifier type="isbn" invalid="yes"/>
  <identifier type="uri">http://www.sciencedirect.com/science/book/9780081000946</identifier>
  <location>
    <url>http://www.sciencedirect.com/science/book/9780081000946</url>
  </location>
  <accessCondition type="restrictionOnAccess">Electronic access restricted to authorized BRAC University faculty, staff and students</accessCondition>
  <recordInfo>
    <recordContentSource authority="marcorg">BD-DhAAL</recordContentSource>
    <recordCreationDate encoding="marc">150928</recordCreationDate>
    <recordChangeDate encoding="iso8601">20191205134905.0</recordChangeDate>
    <recordIdentifier source="BD-DhAAL">AALScienceDirectebook000009</recordIdentifier>
  </recordInfo>
</mods>
